Highly Cited: DZNE Scientists Among the World’s Most Impactful Researchers
Highly Cited Researchers 2025
Bonn (Germany), 12. November 2025. Researchers whose studies are often cited in scientific journals are seen as especially influential, since frequent citations demonstrate that their work is highly valued by the scientific community. In light of this, each year, Clarivate – a company specializing in bibliometric data analysis – publishes a list of the world’s most widely cited researchers. The current edition includes more than 6,800 scientists from various disciplines. Once again, DZNE experts are among those honored as “Highly Cited Researchers”.
The selection is based on thousands of scientific papers published over the past eleven years. Only those publications belonging to the top one percent most cited in their respective research areas were factored into the analysis. Additional criteria were also considered.
Based on this evaluation, the following DZNE researchers have been recognized as “Highly Cited Researchers 2025”:
Prof. Dr. Martin Dichgans, a neurologist, is director of the Institute for Stroke and Dementia Research at the University Hospital of Munich (LMU) and affiliated with DZNE.
![[Translate to Englisch:] Porträt Brit Mollenhauer](/fileadmin/_processed_/0/e/csm_portrait-mollenhauer_69f866d196.jpg)
Prof. Dr. Brit Mollenhauer: The neurologist and expert on Parkinson’s disease is a professor at the Department of Neurology and a research group leader at the University Medical Center Göttingen, head doctor at the Paracelsus Elena Klinic Kassel and affiliated with DZNE.
Prof. Dr. Joachim Schultze is director of Systems Medicine at DZNE, a professor at the University of Bonn and speaker for the program “Neurodegenerative Diseases” of the Helmholtz Association. In addition, he is a pioneer of “Swarm Learning”, an AI-powered technology that enables the analysis of massive data sets and opens up new avenues for medical research.
Prof. Dr. Mikael Simons, a neurologist and neurobiologist, focuses on mechanisms of neurodegenerative diseases. Simons is a research group leader at DZNE’s Munich site and a professor of molecular neurobiology at the Technical University of Munich.